Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1791)	4/29/1998 6:25:00 PM
From: zurdo	Read Replies (1) \| Respond to of 9523

Anthony, it would seem to me that if insurance companies have been covering the earlier less successful ED drugs, it would be extremely difficult to justify, to insurance regulators, their refusal to cover Viagra prescriptions simply for the reason that Viagra is a more effective, thus a more popular drug. That would be discriminatory, and unwarranted. A class action lawsuit could be launched against insurance companies who refuse to cover Viagra for that reason IMHO.